RegWardenFDA facility compliance records
Facility

Bayer Medical Care Inc.

8 recall(s) on record — most severe on record: Class II.

Activity by year

FDA actions on record by year2017: 1 inspections; 2018: 3 recalls; 2020: 1 recalls; 2021: 1 recalls; 2022: 1 recalls; 2026: 2 recalls1201732018201912020120211202220232024202522026
  • Recalls (8)
  • Inspections (1)

Devices registered here (1)

  • Injector And Syringe, Angiographic
    Product code DXT (opens in a new tab) · Class II · Cardiovascular · 21 CFR 870.1650

Recalls & enforcement

  • Class IIOngoing2026-07-31
    Some devices may not have been properly sterilized due to a manufacturing sterilization issue.
  • Class IIOngoing2026-04-24
    Supplier changes resulted in a fit issue with the Contrast Flow Control Valve (CFCV) interface on the Avanta Injector System. Multiple customer reports indicate that the stopcock cannot be reliably engaged with the CFCV snap interface. In instances where engagement is achieved th…
  • Class IIOngoing2022-11-30
    Black specks may be present on the packaged needles
  • Class IITerminated2021-09-14
    Labeling error: MEDRAD Mark 7 Arterion Injection System Syringes (ART 700 SYR) labeled as Twist & Go Syringes (TAG 150 SYR)
  • Class IITerminated2020-10-05
    Specific lots of MEDRAD Stellant FLEX 150 mL syringe kits may have holes and/or cracks that have the potential to allow fluid to leak out of the syringe.
  • Class IITerminated2018-12-14
    If the head mount knob is not properly tightened and the operator directly uses the injector head to move the unit, it may become disengaged, causing the injector head to become loose or fall.
  • Class IITerminated2018-09-07
    Bayer has received reports of loose particulate in the filter when the dust cap is removed. Bayer conducted further testing confirming the dust cap may generate particulate which may potentially enter the fluid path.
  • Class IITerminated2018-06-28
    The torque wrench used on the ceiling column assembly during a recent service visit was outside of the torque specification, potentially overtightening the bolts. The overtightening of bolts may compromise the structural integrity of the system which could lead to the OCS disenga…

FDA inspections (1)

  • NAI2017-01-19
    No Action Indicated · Compliance: Devices; Postmarket Assurance: Devices

Source: U.S. FDA Inspections Dashboard (opens in a new tab) (device inspection classifications, 2016–present). Data as of 2026-10-06. The dashboard profile can take several seconds to load.

Related

Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this facility record at FDA → (opens in a new tab)

Cite this record

RegWarden. “Bayer Medical Care Inc. (FEI 3006791331) — FDA facility record.” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/facility/3006791331-bayer-medical-care-inc/

Not open yet

Alerts for Bayer Medical Care Inc.

Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.

Planned

Want a one-page facility brief?

A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.